Bull/Bear Index 47.2/100
→
"First half taking a breather"... Despite Daewoong Pharmaceutical's target price cut, brokerage expectations are alive, why?
Key takeaway
""First half taking a breather"... Despite Daewoong Pharmaceutical's target price cut, brokerage expectations are alive, why?" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 15 out of 100. Reported by Maeil Business Stock on May 21, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 48.9%.
Join Telegram channel
or scan with phone →